General and comparative efficacy and effectiveness of antidepressants in the acute treatment of depressive disorders: a report by the WPA section of pharmacopsychiatry
✍ Scribed by Thomas C. Baghai; Pierre Blier; David S. Baldwin; Michael Bauer; Guy M. Goodwin; Kostas N. Fountoulakis; Siegfried Kasper; Brian E. Leonard; Ulrik F. Malt; Dan Stein; Marcio Versiani; Hans-Jürgen Möller; for the Section of Pharmacopsychiatry, World Psychiatric Association
- Publisher
- Springer-Verlag
- Year
- 2011
- Tongue
- English
- Weight
- 588 KB
- Volume
- 261
- Category
- Article
- ISSN
- 1433-8491
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
Depression is treated by a great variety of antidepressant treatments. SSRIs (such as fluoxetine) are well known: it is, however, sure that further progress is needed and the search for antidepressants with other mechanisms of action (such as tianeptine) or different efficacy is still of interest. A
AMtracL This 6-week, double-blind, randomised parallel group study was carried out to assess the efficacy and tolerability of 150 mg trazodone nocte and 30-60 mg mianserin nocte in the treatment of depression in general practice. Special emphasis was placed on the effect of treatment on psychomotor
## Abstract ## Background ‘Vascular depression’ may be caused by cerebrovascular disease. Calcium channel blockers, which are putative treatments for cerebrovascular disease, might be expected to improve depression reduction and to prevent recurrence of depression in this patient population. This